123 related articles for article (PubMed ID: 12952560)
1. Validation of the role of angiogenesis as a chemotherapeutic target.
Chu E
Clin Colorectal Cancer; 2003 Aug; 3(2):74-5. PubMed ID: 12952560
[No Abstract] [Full Text] [Related]
2. Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer.
Clin Colorectal Cancer; 2003 Aug; 3(2):85-8. PubMed ID: 12952562
[No Abstract] [Full Text] [Related]
3. [Improving longevity in advanced intestinal cancer].
Schmoll HJ
Krankenpfl J; 2005; 43(1-3):48. PubMed ID: 15912837
[No Abstract] [Full Text] [Related]
4. The treatment of colorectal carcinoma: standard chemotherapy and beyond.
Eng C; Abbruzzese JL
Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242
[TBL] [Abstract][Full Text] [Related]
5. Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study.
Chu E
Clin Colorectal Cancer; 2008 Jul; 7(4):226. PubMed ID: 18650190
[No Abstract] [Full Text] [Related]
6. [Advances in the treatment of metastatic colorectal cancer with bevacizumab].
Longo F; Mansueto G
Tumori; 2006; 92(5):suppl 1-12. PubMed ID: 17168449
[No Abstract] [Full Text] [Related]
7. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
8. First description of an uterine perforation potentially imputable to treatment with bevacizumab.
Uguen T; Leconte B; Desgrippes R; Tchoundeu B; Bretagne JF; Manfredi S
Acta Oncol; 2012 Nov; 51(8):1102-4. PubMed ID: 23020310
[No Abstract] [Full Text] [Related]
9. Always look at the bright side of drugs?
Nygren P
Acta Oncol; 2015 Feb; 54(2):145-7. PubMed ID: 25608927
[No Abstract] [Full Text] [Related]
10. [Angiogenesis targeting in gastro-intestinal cancers].
Meric JB
Bull Cancer; 2007; 94(7 Suppl):F207-15. PubMed ID: 17964998
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab in colorectal cancer.
Sharieff W
N Engl J Med; 2004 Oct; 351(16):1690-1; author reply 1690-1. PubMed ID: 15490497
[No Abstract] [Full Text] [Related]
12. Regarding 'Treatment of colorectal cancer with and without bevacizumab: a phase III study'.
Kabbinavar F; Kozloff M
Oncology; 2011; 80(1-2):135-7; author reply 140-1. PubMed ID: 21677459
[No Abstract] [Full Text] [Related]
13. Bevacizumab targeted therapy: validation of angiogenesis as a key target for advanced colorectal cancer.
Chu E
Clin Colorectal Cancer; 2004 May; 4(1):16. PubMed ID: 15207014
[No Abstract] [Full Text] [Related]
14. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
Dohn LH; Jensen BV; Larsen FO
Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
[No Abstract] [Full Text] [Related]
15. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
[TBL] [Abstract][Full Text] [Related]
16. Comment on 'Treatment of colorectal cancer with and without bevacizumab: a phase III study'.
Boisen MK; Johansen JS; Larsen O; Jensen BV
Oncology; 2011; 80(1-2):138-9. PubMed ID: 21677460
[No Abstract] [Full Text] [Related]
17. Perforating dermatosis in a patient receiving bevacizumab.
Vano-Galvan S; Moreno C; Medina J; Pérez-García B; García-López JL; Jaén P
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):972-4. PubMed ID: 19470057
[No Abstract] [Full Text] [Related]
18. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA, June 2006.
Clin Colorectal Cancer; 2006 Jul; 6(2):109-13. PubMed ID: 16945165
[No Abstract] [Full Text] [Related]
19. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.
Kabbinavar FF; Schulz J; McCleod M; Patel T; Hamm JT; Hecht JR; Mass R; Perrou B; Nelson B; Novotny WF
J Clin Oncol; 2005 Jun; 23(16):3697-705. PubMed ID: 15738537
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".
Giuliani J; Martelli S; Piacentini P; Bonetti A
Tumori; 2015 Mar; 101(1):e32-3. PubMed ID: 25702648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
